128 related articles for article (PubMed ID: 6753896)
1. Acute and chronic effects of captopril therapy in patients with refractory heart failure.
Walsh WF; Lee CL
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):153S-159S. PubMed ID: 6753896
[No Abstract] [Full Text] [Related]
2. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T
Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635
[No Abstract] [Full Text] [Related]
3. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
Maslowski AH; Ikram H; Nicholls MG; Espiner EA
Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
[TBL] [Abstract][Full Text] [Related]
4. [Use of captopril in circulatory failure].
Mareev VIu
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
[No Abstract] [Full Text] [Related]
5. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
[TBL] [Abstract][Full Text] [Related]
6. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
Lee CL; MacDonald GJ; Walsh WF
Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
[No Abstract] [Full Text] [Related]
7. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
9. Clinical improvement and hormonal changes in severe cardiac failure after captopril treatment.
McGrath BP; Denham IM; Johnston CI
Aust N Z J Med; 1981 Dec; 11(6):639-44. PubMed ID: 6277291
[No Abstract] [Full Text] [Related]
10. Factors predicting acute and long-term response to captopril therapy in congestive heart failure.
Levine TB; Cohn JN
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6753898
[No Abstract] [Full Text] [Related]
11. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
Cody RJ; Laragh JH
Am Heart J; 1982 Nov; 104(5 Pt 2):1184-9. PubMed ID: 6291364
[TBL] [Abstract][Full Text] [Related]
12. [A clinical study on treatment of refractory heart failure with oral captopril].
Wang ZS
Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Dec; 11(4):269-72. PubMed ID: 6370641
[No Abstract] [Full Text] [Related]
13. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
Escobar E; Ojeda G; Saavedra M; Thumala A
Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
[No Abstract] [Full Text] [Related]
14. Long-term treatment of congestive heart failure with captopril.
Komajda M; Eugene M; Evans J; Drobinski G; Laurenceau JL; Grosgogeat Y
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):223S-229S. PubMed ID: 6753904
[TBL] [Abstract][Full Text] [Related]
15. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
[TBL] [Abstract][Full Text] [Related]
16. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
[TBL] [Abstract][Full Text] [Related]
17. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
[TBL] [Abstract][Full Text] [Related]
18. [Effects of captopril on plasma renin activity angiotensin II and aldosterone level in cardiac failure patients].
Qin S; Ma C
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Feb; 19(1):29-31. PubMed ID: 2060462
[No Abstract] [Full Text] [Related]
19. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Sharpe DN; Coxon R
Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS
J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
